Clinical Trial Details

EORTC-08092

Back to Clinical Trials Database

Double blind randomized phase III study of maintenance Pazopanib versus placebo in NSCLC patients non progressive after first line chemotherapy.

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 18-Jul-2011
Date Step1 close: 05-Aug-2013
Data management at EORTC Yes
Design Phase 3
Randomized blind
Treatment Pazopanib, Blind trial medication-08092
Study Staff
Type of cancer
Participating groups EORTC Lung Cancer Group
Protocol summary http://clinicaltrials.gov/ct/show/NCT01208064
NCT number NCT01208064
EudraCT 2010-018566-23